Cardiology

A recent study from the ACC Middle East Conference 2019 found patients with hypertension and type 2 diabetes who consume a high fiber diet had improvement in their blood pressure, cholesterol and fasting glucose.

A new study from the Ohio State University found the commonly-prescribed blood cancer drug ibrutinib was linked to new or worsening hypertension, which investigators suggest could contribute to an increase in other cardiovascular events.

The Biovitals Analytics Engine is able to read physiology signals to allow doctors to change the trajectory of disease weeks in advance.

A study from investigators in Europe found the CCS, ACC/AHA, and NICE guidelines for statin use may be more effective at preventing ASCVD events than ESC/EAS or USPSTF guidelines.

Its approval was based on findings from the limited assessment of pediatric patients in PANORAMA-HF, showing reduction of a cardiovascular biomarker.

In a review of chronic kidney disease, investigators suggest a variety of screening and risk reduction measures.

A 41-year-old man whose ECG shows an ST elevation with an upwardly convex descent to an inverted T wave in leads V1 and V2. Labs showed hyperkalemia. What's your diagnosis?

The diabetes management and adult health specialist reacts to the SGLT2 inhibitor's newest indication.

The SGLT2 inhibitor from Janssen has shown significant benefit for reducing progression to end-stage kidney disease, as well as risk for major adverse cardiovascular events.

Elena Myasoedova, MD, of the Mayo Clinic, discusses the results of a study examining the incidence rates of cardiovascular disease in patients with rheumatoid arthritis across 3 decades.

Rania Al Asmar, MBBS, discusses a study she led and authored that examined prevalence and characteristics of patients with rheumatoid arthritis who later developed coronary artery disease.

In new data presented at CCR West, investigators link smoking and ethnicity with organ damage of SLE patients.

The high-sensitivity test may prove to be significantly beneficial for at-risk females, who generally have lower troponin levels than men.

New findings show, despite women making up a greater rate of internal medicine residents, subspecialty fellowships are at a greater disparity now than in 1991.

A study from cardiologists at UPMC Children's Hospital of Pittsburgh examining changes to criteria in 2016, which aimed to improve mortality rates among pediatric candidates for heart transplantation, found rates have worsened for certain conditions.

A Johns Hopkins University study found that donating a kidney was linked to a 19% increase in developing hypertension, regardless of a patient's race.

A new study shows that approximately one-quarter of adults aged 18-34 years old with a medical condition have used marijuna in the past month.

The therapy becomes the first oral GLP-1 agonist approved for the treatment of A1C reduction.

The approved test detects Babesia parasites in red blood cells—an advancement due to the inability to detect parasite in traditional plasma or serum samples.

While better therapies exist to treat patients with heart failure with reduced ejection fraction, there are several hurdles preventing them from being implemented.

Doctors need to use their best judgement when deciding when to use cardiogenic shock devices for temporary mechanical support.

A new American Heart Association and National Institutes of Health-sponsored study found that use of a polypill reduced cardiovascular risk in a low-income population in Mobile, Alabama.

A recent study examining use of popular glucose-lowering medications found that metformin use was associated with fewer cardiovascular events in diabetic patients with reduced kidney function.

How recent trends in heart failure research have shown more priority to patient quality of life outcomes.

How does the broadened sacubitril/valsartan assessment influence the treating confidence of a clinician?

Shaquille O'Neal, EdD, and Elizabeth Ofili, MD, discuss how organizations and physicians are taking novel approaches to engage patients and non-patients about heart failure.

New findings from the trial show daily adherence to the fluid monitoring ReDS system dropped HF patient readmission risk by 58%.